Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Craniofacial morphology linked to childhood sleep-disordered breathing

Children with abnormal craniofacial morphology are at increased risk for having sleep-disordered breathing, say researchers.

3 Jan 2013

Novel implant for craniofacial reconstruction has mixed results

A single-stage, surface-mounted implant designed using the principles of the intraosseous transcutaneous amputation prosthesis is an effective bone anchor for an external prosthesis but may not produce good cosmetic outcomes in complex craniofacial reconstruction, researchers say.

3 Jan 2013

Refined mapping finds over 200 Crohn’s Disease genes

Researchers have used a genetic mapping technique to identify more than 200 genes associated with Crohn’s Disease, making it the most well-characterized disorder to date.

31 Dec 2012

Surgeons: Support your low-income neighbor

Patients with cancer in low-income nations present for surgical treatment at a young age, advanced stage of disease, and often receive palliative rather than curative procedures, suggests a study in Malawi.

28 Dec 2012

DNA adducts linked to oral cancer in smokers

Having a high susceptibility to certain types of DNA damage caused by tobacco smoking could significantly increase the risk for oral cancer, show results of a Taiwanese study.

28 Dec 2012

Ulcerative colitis impairs work capacity

Patients with ulcerative colitis have higher rates of sick leave or disability pension than the general population, show findings published in Gastroenterology.

28 Dec 2012

Genome sequencing may help identify new targets to treat Pneumocystis pneumonia

Scientists have sequenced the genome of the fungus Pneumocystis jirovecii, an advancement that could help identify new targets for drugs to treat and prevent Pneumocystis pneumonia, a common and often deadly infection in immunocompromised patients.

26 Dec 2012

Coffee habit improves survival chances with oral cancer

Drinking more than four cups of coffee per day lowers the risk for death from oral/pharyngeal cancer by almost half compared with drinking none, according to US study findings.

20 Dec 2012

SR9238 compound can reverse effects of fatty liver disease

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed the first synthetic compound that can reverse the effects of a serious metabolic condition known as fatty liver disease. True to its name, the disease involves an abnormal buildup of fat in the liver.

20 Dec 2012

Probiotic supplements can benefit body during and after antibiotic use

Recent data suggests that the average American is bombarded with up to 5,000 varying media messages on a daily basis, which can make it tricky to discern fact from fiction. When it comes to your health, there should be absolutely no doubt that the products you select are effectively working to produce the desired results. This is especially true when it comes to the use of probiotics with antibiotics, because some forms are less effective when combined with antibiotics.

19 Dec 2012

Hypnotherapy helps fight irritable bowel syndrome symptoms

Hypnotherapy helps fight IBS symptoms. These are the findings of a thesis from Sahlgrenska Academy, University of Gothenburg, Sweden which proposes implementing this treatment method into the care of severe sufferers of this common disease.

19 Dec 2012

$Young men, cyclists at risk for facial fractures$

Young men, cyclists at risk for facial fractures

Young men and individuals involved in road accidents on a bicycle are the most likely candidates for maxillofacial fractures, indicate Dutch study results.

18 Dec 2012

Less is more when it comes to antibiotics for UTI in men

Research suggests that standard antibiotic prescribing for urinary tract infections in male patients may need to be reviewed, as currently recommended 7–14-day courses appear to be no more effective than shorter ones, and may increase the risk for antimicrobial resistant or Clostridium difficile infection.

17 Dec 2012

Lexicon receives FDA Fast Track status for development of LX1033 for irritable bowel syndrome

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).

17 Dec 2012

Scientists discover FAIM molecule as potential biomarker for bone marrow cancer

Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow.

14 Dec 2012

UCL scientists discover more than 200 gene locations for Crohn's disease

More than two hundred gene locations have now been identified for the chronic bowel condition Crohn's Disease, in a study that analysed the entire human genome.

13 Dec 2012

Rural residents of Utah less likely to follow colorectal cancer screening recommendations

People who reside in rural areas of Utah are less likely to follow colorectal cancer (CRC) screening recommendations than their urban counterparts, according to researchers from Huntsman Cancer Institute (HCI) at the University of Utah.

13 Dec 2012

Predictor of lymph node metastasis after oral cancer unmasked

The presence of high levels of tumor-associated tissue eosinophilia in early oral squamous cell carcinoma tissue can predict future occult lymph node metastasis, study results show.

13 Dec 2012

Colectomy fails to ease ulcerative colitis sick leave burden

Patients with ulcerative colitis take more time off work than the general population, even after undergoing colectomy, shows a large Swedish study.

13 Dec 2012

Sirtex unveils new website to learn more about SIR-Spheres microspheres

Sirtex today unveiled a new, comprehensive and easy-to-use global website for doctors, nurses, patients and investors interested in learning more about SIR-Spheres microspheres, a form of radiotherapy targeting liver tumours that is gaining increasingly wide acceptance worldwide.

13 Dec 2012